Corriente Advisors’s Turning Point Therapeutics TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-285,000
Closed -$17.8M – 21
2019
Q4
$17.8M Buy
+285,000
New +$13.6M 9.54% 5

Other funds holding TPTX

Corriente Advisors's TPTX Position: Q1 2020 in Review

Corriente Advisors sold out of Turning Point Therapeutics (TPTX) in Q1 2020, closing a stake of 285,000 shares — an estimated $17.8M sold.

Corriente Advisors first reported a position in TPTX in Q4 2019 and held it in 1 quarter. The position peaked at $17.8M in Q4 2019. 119 funds tracked by Wall St. Rank hold TPTX as of Q1 2020.

  • Corriente Advisors reported no remaining Turning Point Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Corriente Advisors sold 285,000 Turning Point Therapeutics shares in Q1 2020, an estimated $17.8M.
  • Corriente Advisors first reported a position in Turning Point Therapeutics in Q4 2019 and held it in 1 quarter.
  • Corriente Advisors's Turning Point Therapeutics position peaked at $17.8M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Turning Point Therapeutics as of Q1 2020.

Based on Corriente Advisors's 13F filing for Q1 2020, filed 18 May 2020.